StockGuru Blog: Genesis Technology – Demonstrates Know How with Chinese Companies
Investing in China — China Becoming Major Pharmaceutical Research Center GTEC Stock Guru Profile Lotus Pharmaceuticals, Inc., has advanced in the development of a treatment for Hepatitis B and also increased its number of local outlets to 15 retail stores. China offers a huge pool of subjects for study and a promising market for any resulting treatments. The cost of research in China is significantly lower than the rest of the world with researchers earning approximately $24,000.00 a year. Lotus is now starting the required animal experimentation. It is expected to reach the market in 2009, and its annual sales…